Virginia Kakla Mani, Professor of Medicine at UT Health San Antonio, share a post on X:
“Estrogen receptor mutations impact treatment in HR+ breast cancer.
I’ll be discussing new screening practices and therapeutic insights with Clinical Care Options at an upcoming live satellite symposium.
I hope you can join me.”
For more updates, follow OncoDaily.